JEENA SIKHO LIFECARE Latest Share Price (JSLL)
TODAY IN ONE LINE
JSLL is little changed at ₹496.85 on light volume — a quiet consolidation day.
With a market cap of ₹6,184.58 Cr., it trades at a P/E of 26.04. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
JEENA SIKHO LIFECARE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 77.5% YoY
- ●High Capital EfficiencyROCE of 51.3% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 47.5%
- ●Healthy Operating MarginsOPM is structurally strong at 38.7%
- ●High Promoter HoldingPromoters hold 63.6% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●FII SellingFII holding decreased by 1.39% QoQ
- ●Rising Receivables vs SalesReceivables grew 214.0% outpacing sales growth of 44.6%
Latest JEENA SIKHO LIFECARE News
What changed recently?
Recent events, corporate actions, and announcements.
JEENA SIKHO LIFECARE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for JEENA SIKHO LIFECARE, framed against the sector median so the premium or discount is obvious at a glance.
JEENA SIKHO LIFECARE trades at a P/E of 26.04× and P/B of 13.19×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
JEENA SIKHO LIFECARE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for JEENA SIKHO LIFECARE — derived from the latest tape, not yesterday's close.
JEENA SIKHO LIFECARE last traded at ₹496.85 with an intraday range of ₹490–₹503.8 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹496.85| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 531.37 | +34.52 | +6.95% |
| R3 | 517.57 | +20.72 | +4.17% |
| R2 | 510.68 | +13.83 | +2.78% |
| R1 | 503.77 | +6.92 | +1.39% |
| PIVOT | 496.88 | 0.03 | 0.01% |
| CURRENT | 496.85 | — | — |
| S1 | 489.97 | -6.88 | -1.39% |
| S2 | 483.08 | -13.77 | -2.77% |
| S3 | 476.17 | -20.68 | -4.16% |
| S4 | 462.37 | -34.48 | -6.94% |
JSLL is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹490–₹503.8
Trading Inside opening range
JEENA SIKHO LIFECARE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for JEENA SIKHO LIFECARE — consolidated or standalone — with margins, YoY growth and key ratios inline.
JEENA SIKHO LIFECARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹6,184.58 Cr. and reported EPS of ₹5.28.
| Metric | Mar 2023 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 205 | 801 ▲ 291.4% |
| Other Income | 3 | 8 ▲ 227.4% |
| Total Income | 207 | 810 ▲ 290.6% |
| 17 | 92 ▲ 425.9% | |
| Gross ProfitDerived | 187 | 710 ▲ 278.9% |
| Gross Margin %Derived | 91.50% | 88.58% |
| 142 | 360 ▲ 154.3% | |
| EBITDA (Operating Profit)Derived | 46 | 349 ▲ 666.2% |
| OPM %Derived | 22.27% | 43.60% |
| 4 | 61 ▲ 1450.0% | |
| Profit Before Tax (PBT) | 44 | 297 ▲ 571.4% |
| 11 | 76 ▲ 602.7% | |
| Effective Tax %Derived | 24.32% | 25.45% |
| Total Profit for Period | 34 | 222 ▲ 561.3% |
| Less: Non-controlling Interests | -0 | -0 ▲ 41.7% |
| Net Profit (Owner's PAT)Derived | 34 | 222 ▲ 556.7% |
| Net Profit Margin %Derived | 16.50% | 27.68% |
| Earnings Per Share (EPS ₹) | 24.46 | 17.85 ▼ 27.0% |
| Diluted Shares Outstanding (Cr) | 1 | 12 ▲ 813.9% |
| Other Comprehensive Income (Net of Tax) | — | 1 |
| Total Expenses (incl. D&A & Interest) | 163 | 512 ▲ 214.3% |
| Material Cost % of RevenueDerived | 0.44% | — |
| Employee Cost % of RevenueDerived | 21.51% | 18.52% |
| Other Cost % of RevenueDerived | 47.71% | 26.46% |
| Interest Coverage (x)Derived | 60.20x | 23.51x |
| Period | Mar 2023 | Mar 2026 | Trend |
|---|---|---|---|
| Revenue from Operations | 205 | 801 ▲ 291.4% | |
| Other Income | 3 | 8 ▲ 227.4% | |
| Total Income | 207 | 810 ▲ 290.6% | |
17 | 92 ▲ 425.9% | ||
| Gross ProfitDerived | 187 | 710 ▲ 278.9% | |
| Gross Margin %Derived | 91.50% | 88.58% | |
142 | 360 ▲ 154.3% | ||
| EBITDA (Operating Profit)Derived | 46 | 349 ▲ 666.2% | |
| OPM %Derived | 22.27% | 43.60% | |
4 | 61 ▲ 1450.0% | ||
| Profit Before Tax (PBT) | 44 | 297 ▲ 571.4% | |
11 | 76 ▲ 602.7% | ||
| Effective Tax %Derived | 24.32% | 25.45% | |
| Total Profit for Period | 34 | 222 ▲ 561.3% | |
| Less: Non-controlling Interests | -0 | -0 ▲ 41.7% | |
| Net Profit (Owner's PAT)Derived | 34 | 222 ▲ 556.7% | |
| Net Profit Margin %Derived | 16.50% | 27.68% | |
| Earnings Per Share (EPS ₹) | 24.46 | 17.85 ▼ 27.0% | |
| Diluted Shares Outstanding (Cr) | 1 | 12 ▲ 813.9% | |
| Other Comprehensive Income (Net of Tax) | — | 1 | |
| Total Expenses (incl. D&A & Interest) | 163 | 512 ▲ 214.3% | |
| Material Cost % of RevenueDerived | 0.44% | — | |
| Employee Cost % of RevenueDerived | 21.51% | 18.52% | |
| Other Cost % of RevenueDerived | 47.71% | 26.46% | |
| Interest Coverage (x)Derived | 60.20x | 23.51x |
JEENA SIKHO LIFECARE segment analysis : revenue and profit mix.
Disclosed business segments at JEENA SIKHO LIFECARE with their share of revenue and profit, switchable between consolidated and standalone reporting.
JEENA SIKHO LIFECARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for JEENA SIKHO LIFECARE.
Our AI distills the core fundamental drivers supporting JEENA SIKHO LIFECARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
JEENA SIKHO LIFECARE's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 34 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 42% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.11%.
JEENA SIKHO LIFECARE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — JEENA SIKHO LIFECARE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
JEENA SIKHO LIFECARE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for JEENA SIKHO LIFECARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
JEENA SIKHO LIFECARE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for JEENA SIKHO LIFECARE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in JEENA SIKHO LIFECARE stood at 43.2% of traded volume, against a 20-day average of 47.4%.
JEENA SIKHO LIFECARE announcements: results, concalls, ratings, M&A.
Filings JEENA SIKHO LIFECARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
JEENA SIKHO LIFECARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 240 documents below.
Postponement of commercial production/operations
Jeena Sikho Lifecare Limited has informed the Exchange about Intimation regarding postponement in commencement of commercial operations at the New…
Postponement of commercial production/operations
Jeena Sikho Lifecare Limited has informed the Exchange about Intimation regarding postponement in commencement of commercial operations at the new…
General Updates
Jeena Sikho Lifecare Limited has informed the Exchange about Receipt of NABH Accreditation for Pune Hospital
Product launch
Jeena Sikho Lifecare Limited has informed the Exchange about Launch of new products
Copy of Newspaper Publication
Jeena Sikho Lifecare Limited has informed the Exchange about Copy of Newspaper Publication for the Notice of 9th AGM, E-Voting Information and…
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Updates
JEENA SIKHO LIFECARE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue JEENA SIKHO LIFECARE has declared, sequenced by announce and record date.
JEENA SIKHO LIFECARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About JEENA SIKHO LIFECARE: business, sector, key facts.
What JEENA SIKHO LIFECARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
JEENA SIKHO LIFECARE operates in the Pharmaceuticals industry under the Healthcare sector.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ABBOTT INDIA (ABBOTINDIA) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- ANLON HEALTHCARE (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about JEENA SIKHO LIFECARE (JSLL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of JEENA SIKHO LIFECARE (JSLL)?
The current share price of JEENA SIKHO LIFECARE (JSLL) is ₹496.85. Today, the stock has declined by ₹0.20 (0.04%), trading in a range of ₹490.00 to ₹503.80. The stock opened at ₹497.05 with a trading volume of 62,302 shares.
02Is JEENA SIKHO LIFECARE stock a good investment for long-term?
JEENA SIKHO LIFECARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹6,184.58 Cr., P/E ratio of 26.04, ROE of 47.48%, and ROCE of 51.27%. The dividend yield stands at 0.22%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of JEENA SIKHO LIFECARE stock?
The 52-week high price of JEENA SIKHO LIFECARE (JSLL) is ₹849.50, while the 52-week low is ₹485.10. Currently trading at ₹496.85, the stock is 2.42% above its 52-week low and 41.51% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy JEENA SIKHO LIFECARE stock at the current price?
Whether to buy JEENA SIKHO LIFECARE stock at ₹496.85 depends on multiple factors. The stock is currently trading with a P/E ratio of 26.04 and P/B ratio of 13.19. Today's performance shows a loss of 0.04%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of JEENA SIKHO LIFECARE and when is the next dividend?
JEENA SIKHO LIFECARE offers a dividend yield of 0.22%, which means for every ₹100 invested at the current price of ₹496.85, you can expect to receive approximately ₹0.22 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of JEENA SIKHO LIFECARE?
JEENA SIKHO LIFECARE's key financial metrics include: P/E Ratio: 26.04, P/B Ratio: 13.19, ROE: 47.48%, ROCE: 51.27%, Dividend Yield: 0.22%, EPS: ₹5.28, Book Value: ₹37.57, and Debt-to-Equity: 0. The company's market cap stands at ₹6,184.58 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is JEENA SIKHO LIFECARE stock performing today in the market?
JEENA SIKHO LIFECARE stock opened at ₹497.05 and is currently trading at ₹496.85, showing a decline of ₹0.20 (0.04%). The intraday high is ₹503.80 and low is ₹490.00. The trading volume stands at 62,302 shares, indicating moderate market participation today.
08What is the P/E ratio of JEENA SIKHO LIFECARE and what does it indicate?
JEENA SIKHO LIFECARE has a Price-to-Earnings (P/E) ratio of 26.04, which means investors are willing to pay 26.04 for every ₹1 of earnings. With an EPS of ₹5.28, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about JEENA SIKHO LIFECARE (JSLL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.